133 related articles for article (PubMed ID: 28336118)
1. Anticoagulation quality control in Primary Care with vitamin K antagonists.
Aguirre Rodriguez JC; Jimenez de la Cruz M; Hidalgo Rodríguez A
Med Clin (Barc); 2017 Jun; 148(12):571-572. PubMed ID: 28336118
[No Abstract] [Full Text] [Related]
2. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.
Speed V; Patel RK; Byrne R; Roberts LN; Arya R
Thromb Res; 2020 Aug; 192():73-74. PubMed ID: 32425265
[No Abstract] [Full Text] [Related]
3. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.
Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR
Europace; 2015 May; 17(5):711-7. PubMed ID: 25662984
[TBL] [Abstract][Full Text] [Related]
5. Laboratory Monitoring of Oral Vitamin K Anticoagulation.
Moffat KA; Lewis CW
Semin Thromb Hemost; 2017 Apr; 43(3):245-252. PubMed ID: 27677177
[TBL] [Abstract][Full Text] [Related]
6. Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH.
Tripodi A; de Laat B; Wahl D; Ageno W; Cosmi B; Crowther M;
J Thromb Haemost; 2016 Nov; 14(11):2304-2307. PubMed ID: 27860336
[No Abstract] [Full Text] [Related]
7. Monitoring oral anticoagulation therapy.
J Assoc Physicians India; 2014 Jun; 62(6 Suppl):30-3. PubMed ID: 25845126
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
9. The HIPOGAIA study: Monitoring of oral anticoagulation with vitamin K antagonists in the municipality of Gaia.
Guedes M; Rego C
Rev Port Cardiol; 2016 Sep; 35(9):459-65. PubMed ID: 27503590
[TBL] [Abstract][Full Text] [Related]
10. [Conditions of resistance to vitamin K antagonists].
Marchal G; Samama M; Charon P
Sem Ther; 1964 Dec; 40(10):623-7. PubMed ID: 5878936
[No Abstract] [Full Text] [Related]
11. Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countries.
Cotté FE; Benhaddi H; Duprat-Lomon I; Doble A; Marchant N; Letierce A; Huguet M
Clin Ther; 2014 Sep; 36(9):1160-8. PubMed ID: 25151574
[TBL] [Abstract][Full Text] [Related]
12. Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease.
Veeger NJ; Piersma-Wichers M; Hillege HL; Crijns HJ; van der Meer J
J Thromb Haemost; 2006 Jul; 4(7):1625-7. PubMed ID: 16839366
[No Abstract] [Full Text] [Related]
13. [In practice: use of vitamin K antagonists].
Heidinger K
Pharm Unserer Zeit; 2004; 33(3):236-43. PubMed ID: 15208912
[No Abstract] [Full Text] [Related]
14. International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing.
Bonar R; Mohammed S; Favaloro EJ
Semin Thromb Hemost; 2015 Apr; 41(3):279-86. PubMed ID: 25839866
[TBL] [Abstract][Full Text] [Related]
15. [Anticoagulant clinics in France? Which usefulness now and for the future?].
Mahé I
Rev Med Interne; 2013 Sep; 34(9):513-4. PubMed ID: 23517772
[No Abstract] [Full Text] [Related]
16. Point-of-care monitoring of vitamin K-antagonists: validation of CoaguChek XS test strips with International Standard thromboplastin.
van den Besselaar AM; Péquériaux NC; Ebben M; van der Feest J; de Jong K; Ganzeboom MB; van Ooijen J; Postema F; Witteveen E; van der Meer FJ
J Clin Pathol; 2012 Nov; 65(11):1031-5. PubMed ID: 22859395
[TBL] [Abstract][Full Text] [Related]
17. Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients.
Schaefer C; Wuillemin WA; Kessels A; Jacobson A; Nagler M
Br J Haematol; 2016 Nov; 175(4):677-685. PubMed ID: 27468696
[TBL] [Abstract][Full Text] [Related]
18. [Vitamin K antagonists: mechanism of anticoagulant action and laboratory control over therapy (a lecture)].
Lipatova NA; Titaeva EV; Dobrovol'skiĭ AB
Klin Lab Diagn; 2006 May; (5):25-32. PubMed ID: 16827235
[No Abstract] [Full Text] [Related]
19. [Control of anticoagulation in patients with non-valvular atrial fibrillation in a primary care clinical practice setting in the different autonomous communities. PAULA study].
Polo García J; Barrios Alonso V; Escobar Cervantes C; Prieto Valiente L; Lobos Bejarano JM; Vargas Ortega D; Prieto Díaz MÁ; Alonso Moreno FJ; Barquilla García A
Semergen; 2017 Apr; 43(3):207-215. PubMed ID: 27422774
[TBL] [Abstract][Full Text] [Related]
20. [Vitamin K antagonists].
Chabalier R; Lévy G
Ann Anesthesiol Fr; 1978; 19(10):IN-5N. PubMed ID: 35048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
